These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8396740)
1. Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry. Geerlings W; Morris RW; Brunner FP; Brynger H; Ehrich JH; Fassbinder W; Rizzoni G; Selwood NH; Tufveson G; Wing AJ Nephrol Dial Transplant; 1993; 8(7):585-9. PubMed ID: 8396740 [TBL] [Abstract][Full Text] [Related]
2. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia]. Stojimirović B; Grujić-Adanja G Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238 [TBL] [Abstract][Full Text] [Related]
3. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
4. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years. Jacobs C; Frei D; Perkins AC Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128 [TBL] [Abstract][Full Text] [Related]
5. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis. Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease. Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U; Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Bárány P; Pettersson E; Konarski-Svensson JK Nephrol Dial Transplant; 1993; 8(5):426-32. PubMed ID: 8393547 [TBL] [Abstract][Full Text] [Related]
10. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M; Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy. Aikhionbare HA; Winterborn MW; Gyde OH Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560 [TBL] [Abstract][Full Text] [Related]
12. [Renal anemia and the effect of long-term dialysis]. Opatrná S; Opatrný K Cas Lek Cesk; 1999 Feb; 138(4):107-10. PubMed ID: 10376407 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy]. Eiselt J; Veselá E; Racek J Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661 [TBL] [Abstract][Full Text] [Related]
14. [Spanish survey on anaemia management]. Pérez García R Nefrologia; 2003; 23(4):300-11. PubMed ID: 14558329 [TBL] [Abstract][Full Text] [Related]
15. Demography of dialysis and transplantation in Europe, 1984. Report from the European Dialysis and Transplant Association Registry. Nephrol Dial Transplant; 1986; 1(1):1-8. PubMed ID: 3110658 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of the sub-target Hb level in children on dialysis. van Stralen KJ; Krischock L; Schaefer F; Verrina E; Groothoff JW; Evans J; Heaf J; Ivanov D; Kostic M; Maringhini S; Podracká L; Printza N; Pundziene B; Reusz GS; Vondrak K; Jager KJ; Tizard EJ; Nephrol Dial Transplant; 2012 Oct; 27(10):3950-7. PubMed ID: 22740719 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Wong CF; McCarthy M; Howse ML; Williams PS Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158 [TBL] [Abstract][Full Text] [Related]
18. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin. Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127 [TBL] [Abstract][Full Text] [Related]
19. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities. House AA; Pham B; Pagé DE Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725 [TBL] [Abstract][Full Text] [Related]
20. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view]. Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]